- Conditions
- Peripheral Neuropathy Due to Chemotherapy
- Interventions
- IncobotulinumtoxinA (Xeomin®, Merz) (INA), Normal saline
- Drug
- Lead sponsor
- Medical College of Wisconsin
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2024
- U.S. locations
- 1
- States / cities
- Milwaukee, Wisconsin
Source: ClinicalTrials.gov public record
Updated Dec 22, 2021 · Synced May 21, 2026, 6:27 PM EDT